Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Nuvolone

Showing results (81-90 of 115) with videos related to

Pageof 12
Sort By:
Blood Advances|February 20, 2025
Diffuse lung involvement as a rare presentation of systemic AL amyloidosis: a retrospective cohort studyAmy Song, George Mellgard, Claudia Bellofiore, et al.
Clinical Chemistry and Laboratory Medicine|January 12, 2022
Prospective urinary albumin/creatinine ratio for diagnosis, staging, and organ response assessment in renal AL amyloidosis: results from a large cohort of patientsMarco Basset, Paolo Milani, Virginia Valeria Ferretti, et al.
Scientific Reports|September 16, 2024
The cellular prion protein does not affect tau seeding and spreading of sarkosyl-insoluble fractions from Alzheimer's diseaseJulia Sala-Jarque, Vanessa Gil, Pol Andrés-Benito, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 28, 2020
Bioelectrical impedance vector analysis-derived phase angle predicts survival in patients with systemic immunoglobulin light-chain amyloidosisRiccardo Caccialanza, Emanuele Cereda, Catherine Klersy, et al.
Clinical Chemistry and Laboratory Medicine|March 27, 2017
Circulating free light chain measurement in the diagnosis, prognostic assessment and evaluation of response of AL amyloidosis: comparison of Freelite and N latex FLC assaysGiovanni Palladini, Arnaud Jaccard, Paolo Milani, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 25, 2017
Identification and quantification of urinary monoclonal proteins by capillary electrophoresis in AL amyloidosisFrancesca Russo, Veronica Valentini, Marco Basset, et al.
Nature Medicine|March 12, 2026
Blood phosphorylated tau elevation as a biomarker in immunoglobulin light chain and transthyretin amyloidosisStephan A Kaeser, Stephanie A Schultz, Anna Hofmann, et al.
Blood|June 8, 2019
Simple, reliable detection of amyloid in fat aspirates using the fluorescent dye FSB: prospective study in 206 patientsMasayoshi Tasaki, Paolo Milani, Andrea Foli, et al.
Clinical Chemistry|January 10, 2009
Identification of amyloidogenic light chains requires the combination of serum-free light chain assay with immunofixation of serum and urineGiovanni Palladini, Paola Russo, Tiziana Bosoni, et al.
Nature|August 9, 2016
The prion protein is an agonistic ligand of the G protein-coupled receptor Adgrg6Alexander Küffer, Asvin K K Lakkaraju, Amit Mogha, et al.
Pageof 12

Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Blood Advances|February 20, 2025
Diffuse lung involvement as a rare presentation of systemic AL amyloidosis: a retrospective cohort studyAmy Song, George Mellgard, Claudia Bellofiore, et al.
Clinical Chemistry and Laboratory Medicine|January 12, 2022
Prospective urinary albumin/creatinine ratio for diagnosis, staging, and organ response assessment in renal AL amyloidosis: results from a large cohort of patientsMarco Basset, Paolo Milani, Virginia Valeria Ferretti, et al.
Scientific Reports|September 16, 2024
The cellular prion protein does not affect tau seeding and spreading of sarkosyl-insoluble fractions from Alzheimer's diseaseJulia Sala-Jarque, Vanessa Gil, Pol Andrés-Benito, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 28, 2020
Bioelectrical impedance vector analysis-derived phase angle predicts survival in patients with systemic immunoglobulin light-chain amyloidosisRiccardo Caccialanza, Emanuele Cereda, Catherine Klersy, et al.
Clinical Chemistry and Laboratory Medicine|March 27, 2017
Circulating free light chain measurement in the diagnosis, prognostic assessment and evaluation of response of AL amyloidosis: comparison of Freelite and N latex FLC assaysGiovanni Palladini, Arnaud Jaccard, Paolo Milani, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 25, 2017
Identification and quantification of urinary monoclonal proteins by capillary electrophoresis in AL amyloidosisFrancesca Russo, Veronica Valentini, Marco Basset, et al.
Nature Medicine|March 12, 2026
Blood phosphorylated tau elevation as a biomarker in immunoglobulin light chain and transthyretin amyloidosisStephan A Kaeser, Stephanie A Schultz, Anna Hofmann, et al.
Blood|June 8, 2019
Simple, reliable detection of amyloid in fat aspirates using the fluorescent dye FSB: prospective study in 206 patientsMasayoshi Tasaki, Paolo Milani, Andrea Foli, et al.
Clinical Chemistry|January 10, 2009
Identification of amyloidogenic light chains requires the combination of serum-free light chain assay with immunofixation of serum and urineGiovanni Palladini, Paola Russo, Tiziana Bosoni, et al.
Nature|August 9, 2016
The prion protein is an agonistic ligand of the G protein-coupled receptor Adgrg6Alexander Küffer, Asvin K K Lakkaraju, Amit Mogha, et al.
Pageof 12